Background Increasing evidence suggests that not only genetics, but also environmental factors like gut microbiota dysbiosis play an important role in the pathogenesis of celiac disease (CD). Aim The aim of our study was to investigate the effect of two probiotic strains Bifidobacterium breve BR03 and B. breve B632 on serum production of anti-inflammatory cytokine interleukin 10 (IL-10) and pro-inflammatory cytokine tumor necrosis factor alpha (TNF-a) in children with CD. Methods The study was a double-blinded, placebo-controlled trial that included 49 children with CD on glutenfree diet (GFD) randomized into two groups and 18 healthy children in the control group. The first group (24 children with CD) daily received B. breve BR03 and B632 (2 9 109 colony-forming units) and the second group (25 children with CD) received placebo for 3 months. Results TNF-a levels were significantly decreased in the first group after receiving B. breve for 3 months. On follow-up, 3 months after receiving probiotics, TNF-a levels increased again. Children with CD who were on GFD for less than 1 year showed similar baseline TNF-a levels as children who were on GFD for more than 1 year. IL-10 levels were in all groups of patients below detection level. Conclusions Probiotic intervention with B. breve strains has shown a positive effect on decreasing the production of pro-inflammatory cytokine TNF-a in children with CD on GFD.
Klemenak, M., Dolinsek, J., Langerholc, T., Di Gioia, D., Micetic-Turk, D. (2015). Administration of Bifidobacterium breve decreases the production of TNF-a in children with celiac disease. DIGESTIVE DISEASES AND SCIENCES, 60, 3386-3392 [10.1007/s10620-015-3769-7].
Administration of Bifidobacterium breve decreases the production of TNF-a in children with celiac disease.
DI GIOIA, DIANA;
2015
Abstract
Background Increasing evidence suggests that not only genetics, but also environmental factors like gut microbiota dysbiosis play an important role in the pathogenesis of celiac disease (CD). Aim The aim of our study was to investigate the effect of two probiotic strains Bifidobacterium breve BR03 and B. breve B632 on serum production of anti-inflammatory cytokine interleukin 10 (IL-10) and pro-inflammatory cytokine tumor necrosis factor alpha (TNF-a) in children with CD. Methods The study was a double-blinded, placebo-controlled trial that included 49 children with CD on glutenfree diet (GFD) randomized into two groups and 18 healthy children in the control group. The first group (24 children with CD) daily received B. breve BR03 and B632 (2 9 109 colony-forming units) and the second group (25 children with CD) received placebo for 3 months. Results TNF-a levels were significantly decreased in the first group after receiving B. breve for 3 months. On follow-up, 3 months after receiving probiotics, TNF-a levels increased again. Children with CD who were on GFD for less than 1 year showed similar baseline TNF-a levels as children who were on GFD for more than 1 year. IL-10 levels were in all groups of patients below detection level. Conclusions Probiotic intervention with B. breve strains has shown a positive effect on decreasing the production of pro-inflammatory cytokine TNF-a in children with CD on GFD.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
